Bioprognos
Early cancer diagnosis via a blood test.
Launch date
Employees
Market cap
-
Enterprise valuation
€2—2m (Dealroom.co estimates Aug 2016.)
Company register number B66693094
Barcelona Catalonia (HQ)
Financials
Estimates*
USD | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | <1m | <1m | <1m | <1m | <1m |
% growth | - | - | (25 %) | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Spinout | ||
€400k | Seed | ||
Total Funding | €400k |
Recent News about Bioprognos
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.